会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明专利
    • ENGINEERED PHENYLALANINE AMMONIA LYASE POLYPEPTIDES
    • SG11201906880VA
    • 2019-08-27
    • SG11201906880V
    • 2018-02-12
    • CODEXIS INC
    • CHNG CHINPINGHALLOWS WILLIAMAGARD NICHOLASALVIZO OSCARDELLAS NIKKIHUISMAN GJALTNICOLS JOHN
    • A61K38/51A61K45/00A61P3/00A61P43/00
    • 0 0 025 (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 16 August 2018 (16.08.2018) WIP0 1 PCT 0111111010 0111 °nolo olommoillin onovoimIE (10) International Publication Number WO 2018/148633 Al (51) International Patent Classification: A61K 38/51 (2006.01) A61P 3/00 (2006.01) A61K 45/00 (2006.01) A61P 43/00 (2006.01) (21) International Application Number: PCT/US2018/017773 (22) International Filing Date: 12 February 2018 (12.02.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/458,232 13 February 2017 (13.02.2017) US 62/565,555 29 September 2017 (29.09.2017) US (71) Applicant: CODEXIS, INC. [US/US]; 200 Penobscot Dri- ve, Redwood City, California 94063 (US). (72) Inventors: CHNG, Chinping; 200 Penobscot Drive, Red- wood City, California 94063 (US). HALLOWS, William, Casey; 200 Penobscot Drive, Redwood City, California 94063 (US). AGARD, Nicholas, J.; 1047 Diamond St., San Francisco, California 94114 (US). ALVIZO, Oscar; 200 Penobscot Drive, Redwood City, California 94063 (US). DELLAS, Nikki; 200 Penobscot Drive, Redwood City, California 94063 (US). HUISMAN, Gjalt, W.; 200 Penobscot Drive, Redwood City, California 94063 (US). NICOLS, John, Joseph; 200 Penobscot Drive, Redwood City, California 94063 (US). (74) Agent: MACKNIGHT, Kamrin, T.; Codexis, Inc., 200 Penobscot Drive, Redwood City, California 94063 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, = (54) Title: ENGINEERED PHENYLALANINE AMMONIA LYASE POLYPEPTIDES -4- Av PAL PBS - Av PAL FaSSIF -A- Av PAL FeSSIF Early -v- Av PAL FeSSIF Middle - Av PAL FeSSIF Late -o- Variant 126 PBS -o- Variant 126 FaSSIF - 6 - Variant 126 FeSSIF Early Variant 126 FeSSIF Middle - o- Variant 126 FeSSIF Late 0.00 0 2 4 6 8 10 15 20 25 30 Time (hrs) FIG. 1 (57) : The present invention provides engineered phenylalanine ammonia lyase (PAL) polypeptides and compositions thereof, as well as polynucleotides encoding the engineered phenylalanine ammonia lyase (PAL) polypeptides. In some embodiments, the engi- neered PAL polypeptides are optimized to provide enhanced catalytic activity, as well as reduced sensitivity to proteolysis and increased tolerance to storage at elevated temperatures. In some embodiments, the engineered PAL polypeptides contain fewer phenylalanine residues than wild-type PAL polypeptides. The present invention also provides methods for the use of the compositions comprising the engineered PAL polypeptides for therapeutic and industrial purposes. C [Continued on next page] WO 2018/148633 Al MIDEDIMOMOIDEIREEMOMMIVE110110100MEMOIS OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: with international search report (Art. 21(3)) before the expiration of the time limit for amending the claims and to be republished in the event of receipt of amendments (Rule 48.2(h)) with sequence listing part of description (Rule 5.2(a))